Emily Greengard

7PUBLICATIONS
19CO-AUTHORS
Medical devicesInfant and child healthMolecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Feb 12, 2026
HeartWare™ HVAD support without anticoagulation.

Mats Steffi Jennifer Masilamani, Emily Greengard, Jonathan Nicholas Johnson

|Nov 06, 2024
Impact of the COVID-19 Pandemic Onset on the Early Careers of Pediatric Oncology Health Professionals and Researchers: A Report From the Children's Oncology Group Young Investigators Committee, Young SIOP Network, and Young SIOPE.

Gemma Bryan, Louise Guolla, Gabriela Inés Villanueva

|Jun 13, 2024
Population modeling analyses of crizotinib in pediatric patients with ALK-positive advanced cancers.

Li Jerry, Lin Swan, Nickens Dana

|Mar 23, 2024
A phase 1/2 study of pepinemab in children, adolescents, or young adults with recurrent or refractory solid tumors: A children's oncology group consortium report (ADVL1614).

Emily Greengard, Robin Williams, Branden Moriarity

|Oct 23, 2021
Long Non-Coding RNA <i>ANRIL</i> as a Potential Biomarker of Chemosensitivity and Clinical Outcomes in Osteosarcoma.

Adam M Lee, Asmaa Ferdjallah, Elise Moore

|Oct 23, 2020
Safety, tolerability and pharmacokinetics of crizotinib in combination with cytotoxic chemotherapy for pediatric patients with refractory solid tumors or anaplastic large cell lymphoma (ALCL): a Children's Oncology Group phase 1 consortium study (ADVL1212).

Emily Greengard, Yael P Mosse, Xiaowei Liu

Pageof 2

Frequent Collaborators

1 joint publications

Daniel C Kim

1 joint publications

R Stephanie Huang

1 joint publications

Stephan Voss

1 joint publications

Li Jerry